The essential role of high-dose IL-2 in cancer has now been widely discussed, especially because IL-2 is suspected to optimize all stages of CD8+ T cell response, including primary expansion, contraction, memory generation, and secondary expansion31. This evidence concerns the gene CD8A and cancer.